Rutgers cancer center promotes 2 leaders
Rutgers Cancer Institute of New Jersey promotes two leadership positions to support new cancer center opening in 2025. Learn more in this news release.
Stay updated with breaking news from Andrew Evens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rutgers Cancer Institute of New Jersey promotes two leadership positions to support new cancer center opening in 2025. Learn more in this news release.
Andrew Evens, DO, MBA, MSc, highlights key points presented during the 2023 Rutgers Cancer Institute of New Jersey’s Annual Oncology Clinical Practice and Research Summit, the clinical implications of these presentations, and lymphoma treatment innovations that Rutgers Cancer Institute is providing to patients throughout New Jersey.
Results include a landmark study that involved seamless collaboration across adult and pediatric patient groups, leading to a highly diverse study population. Other coverage addresses access to novel therapies and what's coming in the pipeline, including CAR T-cell therapy with tyrosine kinase inhibitors.
For the first time, researchers sought to analyze the outcomes of pregnant women with r/r lymphoma based on the timing of the pregnancy and type of lymphoma.
FRIDAY, June 2, 2023 (HealthDay News) -- Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.